The UDP-sugar-sensing P2Y(14) receptor promotes Rho-mediated signaling and chemotaxis in human neutrophils.
暂无分享,去创建一个
T. K. Harden | E. Lazarowski | S. Kreda | R. García-Mata | H. Dang | J. Sesma | N. Steinckwich-Besançon | T. Harden | T. K. Harden | T. Harden
[1] S. O’Grady. Purinergic signaling and immune cell chemotaxis. Focus on "the UDP-sugar-sensing P2Y14 receptor promotes Rho-mediated signaling and chemotaxis in human neutrophils". , 2012, American journal of physiology. Cell physiology.
[2] P. Insel,et al. New insights regarding the regulation of chemotaxis by nucleotides, adenosine, and their receptors , 2012, Purinergic Signalling.
[3] P. Kubes,et al. Sensing sterile injury: opportunities for pharmacological control. , 2011, Pharmacology & therapeutics.
[4] Seiko F. Okada,et al. Coupled nucleotide and mucin hypersecretion from goblet-cell metaplastic human airway epithelium. , 2011, American journal of respiratory cell and molecular biology.
[5] J. Sévigny,et al. NTPDase1 Controls IL-8 Production by Human Neutrophils , 2011, The Journal of Immunology.
[6] Seiko F. Okada,et al. Rho Signaling Regulates Pannexin 1-mediated ATP Release from Airway Epithelia* , 2011, The Journal of Biological Chemistry.
[7] G. Danuser,et al. Protein Kinase A Governs a RhoA-RhoGDI Protrusion-Retraction Pacemaker in Migrating Cells , 2011, Nature Cell Biology.
[8] I. von Kügelgen,et al. Molecular pharmacology, physiology, and structure of the P2Y receptors. , 2011, Advances in pharmacology.
[9] E. Lazarowski,et al. Molecular mechanisms of purine and pyrimidine nucleotide release. , 2011, Advances in pharmacology.
[10] P. Kubes,et al. Intravascular Danger Signals Guide Neutrophils to Sites of Sterile Inflammation , 2010, Science.
[11] W. Junger,et al. Purinergic Signaling: A Fundamental Mechanism in Neutrophil Activation , 2010, Science Signaling.
[12] T. K. Harden,et al. Signalling and pharmacological properties of the P2Y14 receptor , 2010, Acta physiologica.
[13] K. Jacobson,et al. UDP‐glucose acting at P2Y14 receptors is a mediator of mast cell degranulation , 2010, Biochemical pharmacology.
[14] E. Lazarowski. Quantification of extracellular UDP-galactose. , 2010, Analytical biochemistry.
[15] K. Jacobson,et al. Quantification of Gi-Mediated Inhibition of Adenylyl Cyclase Activity Reveals That UDP Is a Potent Agonist of the Human P2Y14 Receptor , 2009, Molecular Pharmacology.
[16] Gaudenz Danuser,et al. Coordination of Rho GTPase activities during cell protrusion , 2009, Nature.
[17] R. Marée,et al. P2X1 Ion Channels Promote Neutrophil Chemotaxis through Rho Kinase Activation , 2009 .
[18] T. K. Harden,et al. Gi-Dependent Cell Signaling Responses of the Human P2Y14 Receptor in Model Cell Systems , 2009, Journal of Pharmacology and Experimental Therapeutics.
[19] T. Nagashima,et al. The UDP-Glucose Receptor P2RY14 Triggers Innate Mucosal Immunity in the Female Reproductive Tract by Inducing IL-81 , 2009, The Journal of Immunology.
[20] E. Lazarowski,et al. Endoplasmic Reticulum/Golgi Nucleotide Sugar Transporters Contribute to the Cellular Release of UDP-sugar Signaling Molecules* , 2009, Journal of Biological Chemistry.
[21] P. Insel,et al. Ecto-nucleoside Triphosphate Diphosphohydrolase 1 (E-NTPDase1/CD39) Regulates Neutrophil Chemotaxis by Hydrolyzing Released ATP to Adenosine* , 2008, Journal of Biological Chemistry.
[22] A. Ault,et al. Similarities between UDP-glucose and adenine nucleotide release in yeast: involvement of the secretory pathway. , 2008, Biochemistry.
[23] K. Jacobson,et al. UDP Is a Competitive Antagonist at the Human P2Y14 Receptor , 2008, Journal of Pharmacology and Experimental Therapeutics.
[24] E. Lazarowski,et al. Thrombin‐promoted release of UDP‐glucose from human astrocytoma cells , 2008, British journal of pharmacology.
[25] G. Dubyak,et al. The inflammatory effects of UDP-glucose in N9 microglia are not mediated by P2Y14 receptor activation , 2008, Purinergic Signalling Purinergic Signalling.
[26] H. Bourne,et al. PDZRhoGEF and myosin II localize RhoA activity to the back of polarizing neutrophil-like cells , 2007, The Journal of cell biology.
[27] A. Surprenant,et al. Inhibition of Neutrophil Apoptosis by ATP Is Mediated by the P2Y11 Receptor1 , 2007, The Journal of Immunology.
[28] Seiko F. Okada,et al. Coordinated release of nucleotides and mucin from human airway epithelial Calu‐3 cells , 2007, The Journal of physiology.
[29] J. V. van Buul,et al. VEGF-induced Rac1 activation in endothelial cells is regulated by the guanine nucleotide exchange factor Vav2. , 2007, Experimental cell research.
[30] M. J. Broekman,et al. CD39/NTPDase-1 activity and expression in normal leukocytes. , 2007, Thrombosis research.
[31] Linda Yip,et al. ATP Release Guides Neutrophil Chemotaxis via P2Y2 and A3 Receptors , 2006, Science.
[32] J. Dickenson,et al. Functional expression of the P2Y14 receptor in human neutrophils. , 2006, European journal of pharmacology.
[33] A. Mollica,et al. Signal transduction pathways triggered by selective formylpeptide analogues in human neutrophils. , 2006, European journal of pharmacology.
[34] F. Di Virgilio,et al. The P2Y14 receptor of airway epithelial cells: coupling to intracellular Ca2+ and IL-8 secretion. , 2005, American journal of respiratory cell and molecular biology.
[35] J. Cherfils,et al. Uncoupling of Inhibitory and Shuttling Functions of Rho GDP Dissociation Inhibitors* , 2005, Journal of Biological Chemistry.
[36] R. Ye,et al. A Rho Exchange Factor Mediates fMet-Leu-Phe-induced NF-κB Activation in Human Peripheral Blood Monocytes* , 2004, Journal of Biological Chemistry.
[37] V. Niggli. Signaling to migration in neutrophils: importance of localized pathways. , 2003, The international journal of biochemistry & cell biology.
[38] P. Emson,et al. GPR105, a novel Gi/o-coupled UDP-glucose receptor expressed on brain glia and peripheral immune cells, is regulated by immunologic challenge: possible role in neuroimmune function. , 2003, Brain research. Molecular brain research.
[39] A. Platt,et al. Human Immature Monocyte-Derived Dendritic Cells Express the G Protein-Coupled Receptor GPR105 (KIAA0001, P2Y14) and Increase Intracellular Calcium in Response to its Agonist, Uridine Diphosphoglucose , 2003, The Journal of Immunology.
[40] Jingsong Xu,et al. Divergent Signals and Cytoskeletal Assemblies Regulate Self-Organizing Polarity in Neutrophils , 2003, Cell.
[41] D. Haber,et al. P2Y-like receptor, GPR105 (P2Y14), identifies and mediates chemotaxis of bone-marrow hematopoietic stem cells. , 2003, Genes & development.
[42] R. Boucher,et al. Release of cellular UDP-glucose as a potential extracellular signaling molecule. , 2003, Molecular pharmacology.
[43] V. V. van Hinsbergh,et al. Involvement of RhoA/Rho Kinase Signaling in VEGF-Induced Endothelial Cell Migration and Angiogenesis In Vitro , 2003, Arteriosclerosis, thrombosis, and vascular biology.
[44] D. Mukhopadhyay,et al. KDR Stimulates Endothelial Cell Migration through Heterotrimeric G Protein Gq/11-mediated Activation of a Small GTPase RhoA* , 2002, The Journal of Biological Chemistry.
[45] P. Emson,et al. Cloning, pharmacology, and tissue distribution of G-protein-coupled receptor GPR105 (KIAA0001) rodent orthologs. , 2001, Genomics.
[46] P. Hordijk,et al. Activation of Rhoa and ROCK are essential for detachment of migrating leukocytes. , 2001, Molecular biology of the cell.
[47] R. Boucher,et al. Constitutive Release of ATP and Evidence for Major Contribution of Ecto-nucleotide Pyrophosphatase and Nucleoside Diphosphokinase to Extracellular Nucleotide Concentrations* , 2000, The Journal of Biological Chemistry.
[48] J. Chambers,et al. A G Protein-coupled Receptor for UDP-glucose* , 2000, The Journal of Biological Chemistry.
[49] T. K. Harden,et al. Quantitation of extracellular UTP using a sensitive enzymatic assay , 1999, British journal of pharmacology.
[50] V. Niggli. Rho‐kinase in human neutrophils: a role in signalling for myosin light chain phosphorylation and cell migration , 1999, FEBS letters.
[51] G. Dubyak,et al. The P2X1 receptor, an adenosine triphosphate-gated cation channel, is expressed in human platelets but not in human blood leukocytes. , 1998, Blood.
[52] F. Sistare,et al. Distribution of P2Y receptor subtypes on haematopoietic cells , 1998, British journal of pharmacology.
[53] Robert Kay,et al. Lfc and Lsc Oncoproteins Represent Two New Guanine Nucleotide Exchange Factors for the Rho GTP-binding Protein* , 1996, The Journal of Biological Chemistry.
[54] J. Boucheron,et al. P2U Agonists Induce Chemotaxis and Actin Polymerization in Human Neutrophils and Differentiated HL60 Cells* , 1996, The Journal of Biological Chemistry.
[55] A. Surprenant,et al. P2X1 receptor activation in HL60 cells. , 1996, Blood.
[56] David A. Williams,et al. Novel human oncogene lbc detected by transfection with distinct homology regions to signal transduction products. , 1994, Oncogene.
[57] Anika Niambi Al-Shura. Leukocytes. , 1994, Current opinion in hematology.
[58] E. Lazarowski,et al. Aggregation of human neutrophils by heparin. , 1986, Thrombosis research.